Table 2.
Solubility of MF, DDN and CLA in solid lipid excipients.
| MF (0.005 g) |
DDN (0.01 g) |
CLA (0.01 g) |
|||
|---|---|---|---|---|---|
| Lipid | Amount(g) | Lipid | Amount(g) | Lipid | Amount(g) |
| Compritol® 888 ATO | – | Compritol® 888 ATO | 3.0 | Compritol® 888 ATO | – |
| Precirol® ATO 5 | – | Precirol® ATO 5 | 4.0 | Precirol® ATO 5 | – |
| Gelucire® 48/16 | 7.0 | Gelucire® 48/16 | – | Gelucire® 48/16 | – |
| Cetyl palmitate | – | Cetyl palmitate | – | Cetyl palmitate | – |
| Stearic acid | – | Stearic acid | – | Stearic acid | 3.0 |
| Geleol™ | 6.0 | Geleol™ | – | Geleol™ | – |
-Complete solubilization of API not achieved as lipid(s) with best solubilization potential for the API had been identified.